Interleukin 35: a key mediator of suppression and the propagation of infectious tolerance.
about
Regulatory T Cells: Molecular Actions on Effector Cells in Immune RegulationTranscriptomic Analysis of Persistent Infection with Foot-and-Mouth Disease Virus in Cattle Suggests Impairment of Apoptosis and Cell-Mediated Immunity in the NasopharynxIL-35 induces N2 phenotype of neutrophils to promote tumor growth.Regulatory T cells in multiple sclerosis and myasthenia gravis.Function of interleukin-17 and -35 in the blood of patients with hepatitis B-related liver cirrhosis.The immune system in Duchenne muscular dystrophy: Friend or foe.Human tolerogenic dendritic cells produce IL-35 in the absence of other IL-12 family members.Mucosal Administration of Collagen V Ameliorates the Atherosclerotic Plaque Burden by Inducing Interleukin 35-dependent Tolerance.Elevated serum IL-35 and increased expression of IL-35-p35 or -EBI3 in CD4(+)CD25(+) T cells in patients with active tuberculosis.IL-27 Induced by Select Candida spp. via TLR7/NOD2 Signaling and IFN-β Production Inhibits Fungal Clearance.Patterns of Immune Regulation in Rhesus Macaque and Human FamiliesEffects of an intravitreal injection of interleukin-35-expressing plasmid on pro-inflammatory and anti-inflammatory cytokines.Exosomes: The missing link between microchimerism and acquired tolerance?Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression.Elevated level of interleukin-35 in colorectal cancer induces conversion of T cells into iTr35 by activating STAT1/STAT3.Responses to LPS boost effector CD8 T-cell accumulation outside of signals 1 and 2.Clinical implications of basic science discoveries: janus resurrected--two faces of B cell and plasma cell biology.Interleukin-12 family cytokines and sarcoidosis.IL-35: a potential therapeutic target for controlling hepatitis B virus infection.Interleukin-35 as a predictor of prostate cancer in patients undergoing initial prostate biopsy.IL-35 Suppresses Lipopolysaccharide-Induced Airway Eosinophilia in EBI3-Deficient Mice.A review on interleukins: The key manipulators in rheumatoid arthritis.Expanding Diversity and Common Goal of Regulatory T and B Cells. I: Origin, Phenotype, Mechanisms.The function of regulatory T cells at the ocular surface: Review.Cardiac Autoimmunity: Myocarditis.Level of Interleukin-35 in Gingival Crevicular Fluid, Saliva, and Plasma in Periodontal Disease and Health.The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part I: Treg properties and functions.Thymus-Derived, Peripherally Derived, and in vitro-Induced T Regulatory Cells.The antiviral immune response in human conventional dendritic cells is controlled by the mammalian target of rapamycin.Immune Checkpoints in Leprosy: Immunotherapy As a Feasible Approach to Control Disease Progression.Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis.Lower level of IL‑35 and its reduced inhibition in Th17 cells in patients with bone marrow mononuclear cells Coombs test‑positive hemocytopenia.Mesenchymal Stem Cells Overexpressing Interleukin-35 Propagate Immunosuppressive Effects in Mice.Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness.Overexpression of IL-35 in intrahepatic cholangiocarcinoma isa prognostic indicator after curative resection.Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.The Role, Involvement and Function(s) of Interleukin-35 and Interleukin-37 in Disease Pathogenesis.Macrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonizationRegulatory T cells and asthma
P2860
Q26746113-4C74FFEE-B324-42DB-BC7A-118B5F217A98Q27322442-D1646C63-E895-42E1-AB62-7A0E154A4F74Q33779538-E3E38812-305A-4D83-8596-3F4F19737890Q33784969-919C8C14-60E0-4B74-B1F5-9C11E5CC9695Q34540813-84520325-2971-41D6-B8FC-8E25304A76C4Q36105761-AEEC8E85-3E5C-454F-8C8A-0763743B429CQ36198449-C7456D68-23C0-427A-8B12-21E718A8D2B6Q36573968-6EA8EAF6-7D1A-4C8E-A8D0-1C16E4735EADQ36841195-FCE1213E-F835-4D3A-944C-13FBBB02E512Q37015050-B706BB08-CE17-4AE5-B393-636E8547EF02Q37097734-C6C76219-F281-4F3A-B527-580C1123BF47Q37187572-A4255DE0-BA7C-4202-9A04-5BD1A9AAFB4FQ37337117-2DDA1B18-1B6D-4B1F-81D6-73AB0FAE358EQ37598465-5354DBAC-C4F0-40D3-BA85-C9C047553716Q37687332-13F72A0B-CC97-49ED-BC7E-A8862C978245Q37714634-056982F0-0D92-46E6-ACB8-48DC2C180A34Q38266375-10C8A591-C041-4035-974A-172B066B2E85Q38266881-0BEE4199-1BB5-4124-B9A6-5B9C416231DBQ38283391-D7AA6AC1-7403-4029-A352-753ED2B75604Q38650594-05AE9841-F3D5-4C49-BCA5-84FF52822BCFQ38729193-C3966816-446E-4398-8CA8-EB7D99BEED2AQ39029629-3B74D846-3DF2-4755-8878-6F582232F1B1Q39287039-F83C0C9B-3193-460F-A000-90A89E4F98BEQ39347374-04549877-B1A2-4208-BD66-8680EBFF0CE7Q40138726-F0E26A9B-2A2C-4081-BFB8-F8205BE576FBQ41197467-E455B7C5-D709-43DF-9A9D-22D1A4F63D00Q41690249-F8D06D55-EB1A-4B9E-8950-7CAF44D5DFADQ41889070-54217FBE-23C1-459B-9F3B-5DE97E48DBA4Q42207619-51B26ACC-C90C-47DE-B507-5B1735B221ACQ47221330-311AD2F7-B86F-4D60-AC41-234E1193E3A5Q47552983-FD681019-8C53-44EF-8F5D-FBCD57028E71Q47563556-BE11B07D-7BAE-4C65-98AA-0342A8D7BB53Q47829774-EE42A61B-CCDC-469A-83D3-14AF32C2CB4EQ49276761-F1DEB147-A7E8-4887-AA72-A7875B7EE0E8Q49984762-E1A514EF-E672-4A3A-84D7-418F86A334BFQ51036730-D5DBB123-C99A-4912-A014-C068BC0C2C6CQ52594247-8F07CBBD-0388-4BA7-A3BE-AB411EB2B13FQ58740853-90D80839-3F34-4407-9F40-D0E1D3A22C8DQ58775100-F88922FC-4E4F-470F-9B28-12FB5EA5EDF5
P2860
Interleukin 35: a key mediator of suppression and the propagation of infectious tolerance.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Interleukin 35: a key mediator ...... ation of infectious tolerance.
@en
type
label
Interleukin 35: a key mediator ...... ation of infectious tolerance.
@en
prefLabel
Interleukin 35: a key mediator ...... ation of infectious tolerance.
@en
P2093
P2860
P356
P1476
Interleukin 35: a key mediator ...... ation of infectious tolerance.
@en
P2093
Brian M Olson
Jeremy A Sullivan
William J Burlingham
P2860
P356
10.3389/FIMMU.2013.00315
P577
2013-10-18T00:00:00Z